Funding for this research was provided by:
National Institutes of Health (R01 MH110259, U24 MH100931, R01 DA040391, R01 MH097659, U24 MH100930, U24 MH100925, U24 MH100928, U24 MH100929)
Received: 29 August 2019
Accepted: 10 October 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: This study included CSF samples and data from the National NeuroAIDS Tissue Consortium (NNTC) (Manhattan HIV Brain Bank, National Neurological AIDS Bank, California NeuroAIDS Tissue Network, and Texas NeuroAIDS Research Center). All subjects were enrolled with written informed consent and institutional review board (IRB) approval at each study site. The use of de-identified samples and data for the study was approved by the Dana-Farber Cancer Institute Institutional Review Board.
: Not applicable
: The authors declare that they have no competing interests.